Aspen Pharmacare

Member of UN Global Compact

Aspen Pharmacare website

🔎 Run a search for “Aspen Pharmacare”

Get RSS feed of these results

All stories

Article
29 June 2015
+ Français - Hide
Article
3 July 2009
+ Français - Hide

Author: Destination Santé

Le laboratoire Roche annonce le lancement du Tamiflu Reserves Program (TRP) développé pour les pays défavorisés. L’objectif est de garantir à un coût réduit, l’accès à cet antiviral de référence contre la grippe pandémique. [fait aussi référence à...

Read more

Story
9 October 2008

Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions

See full story

Article
9 October 2008

Secretary-General's statement following meeting with pharmaceutical and diagnostic companies working on HIV and AIDS

Author: United Nations

I met today with senior executives of seventeen of the world's research-based and generic pharmaceutical and diagnostic companies…to review progress on...expand[ing] access to HIV prevention, treatment, care and support services in low- and middle...

Read more

Article
1 July 2008

[PDF] Creating Value for All: Strategies for Doing Business with the Poor

Author: United Nations Development Programme

This report shows how entrepreneurs can serve the poor as clients and customers and can also include the poor as producers, employees and business owners. It gives many examples of firms that—by doing business with the poor—are generating profits,...

Read more

Article
1 July 2008
+ Français - Hide

Author: Programme des Nations Unies pour le développement

Ce rapport montre comment les entrepreneurs peuvent servir les populations pauvres en tant que clientes, mais aussi les intégrer en tant que producteurs, employés et chefs d’entreprise. Il donne des exemples de sociétés qui, en faisant affaire avec...

Read more

Story
1 July 2008
+ Français - Hide
Article
5 April 2007

Aspen to market last-resort Aids drug across Africa

Author: Samantha Enslin, Business Report [So. Africa]

Aspen plans to market a salvage treatment, Prezista, for Aids patients in 20 sub-Saharan African countries through a deal with Ireland's Tibotec Pharmaceuticals [a division of Johnson & Johnson (J&J)]...The deal was structured so that Aspen...

Read more

Article
9 February 2007

MCC [Medicines Control Council] stalls new Aids drugs [South Africa]

Author: Belinda Beresford, Mail & Guardian

South Africans have been denied the “biggest advance” in antiretroviral therapy…because of a lack of urgency in the drug registration process…according to the Treatment Action Campaign [TAC]. The TAC is calling for the urgent registration of Tenofovir...

Read more

Article
25 September 2006

Indian Firms to Make HIV Drug - Gilead Sciences licenses AIDS treatment Tenofovir to eight more Indian companies

Author: Red Herring [USA]

Eight more Indian companies have received nonexclusive licenses from Gilead Sciences to manufacture and distribute the HIV drug Tenofovir...The [eight] Indian drug companies that struck the licensing deal were [Ranbaxy Laboratories], Aurobindo Pharma,...

Read more